Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 β3-adrenoceptors: a drug target in ophthalmology?

Literature DB >> 23344523

β3-adrenoceptors: a drug target in ophthalmology?

Adrian Gericke, Tobias Böhmer, Martin C Michel.

Abstract

Mesh：

Substances：

Year: 2013 PMID： 23344523 DOI： 10.1007/s00210-013-0835-6

Source DB: PubMed Journal: Naunyn Schmiedebergs Arch Pharmacol ISSN： 0028-1298 Impact factor: 3.000

× No keyword cloud information.

27 in total

1. Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.

Authors: J D Bloom; M D Dutia; B D Johnson; A Wissner; M G Burns; E E Largis; J A Dolan; T H Claus
Journal: J Med Chem Date: 1992-08-07 Impact factor: 7.446

2. Pharmacological evidence for the presence of functional beta(3)-adrenoceptors in rat retinal blood vessels.

Authors: Asami Mori; Tomoyo Miwa; Kenji Sakamoto; Tsutomu Nakahara; Kunio Ishii
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2010-05-26 Impact factor: 3.000

3. Relaxant effects of beta-adrenoceptor agonist formoterol and BRL 37344 on bovine iris sphincter and ciliary muscle.

Authors: Aysen Topalkara; Baris Karadas; Mustafa I Toker; Tijen Kaya; Nedim Durmus; Bulent Turgut
Journal: Eur J Pharmacol Date: 2006-08-16 Impact factor: 4.432

4. Beta 3-adrenergic receptors mediate choroidal endothelial cell invasion, proliferation, and cell elongation.

Authors: Jena J Steinle; David O Zamora; James T Rosenbaum; Harris J Granger
Journal: Exp Eye Res Date: 2005-01 Impact factor: 3.467

5. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs.

Authors: J R Arch; A T Ainsworth; M A Cawthorne; V Piercy; M V Sennitt; V E Thody; C Wilson; S Wilson
Journal: Nature Date: 1984 May 10-16 Impact factor: 49.962

6. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

Authors: Chiara Ristori; Luca Filippi; Massimo Dal Monte; Davide Martini; Maurizio Cammalleri; Pina Fortunato; Giancarlo la Marca; Patrizio Fiorini; Paola Bagnoli
Journal: Invest Ophthalmol Vis Sci Date: 2011-01-05 Impact factor: 4.799

7. Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.

Authors: Martin C Michel; Hana Cernecka; Peter Ochodnicky
Journal: Eur J Pharmacol Date: 2011-02-12 Impact factor: 4.432

8. Specificity evaluation of antibodies against human β3-adrenoceptors.

Authors: Hana Cernecka; Peter Ochodnicky; Wouter H Lamers; Martin C Michel
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2012-06-12 Impact factor: 3.000

9. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

Authors: E A Pierce; E D Foley; L E Smith
Journal: Arch Ophthalmol Date: 1996-10

10. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors: E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal: Proc Natl Acad Sci U S A Date: 1995-01-31 Impact factor: 11.205

3 in total